HK1249865B - 疼痛的治療 - Google Patents

疼痛的治療

Info

Publication number
HK1249865B
HK1249865B HK18109397.0A HK18109397A HK1249865B HK 1249865 B HK1249865 B HK 1249865B HK 18109397 A HK18109397 A HK 18109397A HK 1249865 B HK1249865 B HK 1249865B
Authority
HK
Hong Kong
Prior art keywords
pain
treatment
Prior art date
Application number
HK18109397.0A
Other languages
English (en)
Inventor
Isabel Gonzalez
Martyn Pritchard
Peter Richardson
Original Assignee
Benevolentai Cambridge Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benevolentai Cambridge Ltd filed Critical Benevolentai Cambridge Ltd
Publication of HK1249865B publication Critical patent/HK1249865B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
HK18109397.0A 2015-04-24 2018-07-19 疼痛的治療 HK1249865B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1507048.5A GB201507048D0 (en) 2015-04-24 2015-04-24 Treatment of pain
PCT/GB2016/051122 WO2016170353A1 (en) 2015-04-24 2016-04-22 Treatment of pain

Publications (1)

Publication Number Publication Date
HK1249865B true HK1249865B (zh) 2019-12-06

Family

ID=53488643

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18109397.0A HK1249865B (zh) 2015-04-24 2018-07-19 疼痛的治療

Country Status (22)

Country Link
US (1) US20180104223A1 (zh)
EP (1) EP3285767B8 (zh)
JP (2) JP2018520984A (zh)
KR (1) KR20170139047A (zh)
CN (1) CN107530330A (zh)
AU (1) AU2016252237B2 (zh)
BR (1) BR112017019337A2 (zh)
CA (1) CA2979160A1 (zh)
DK (1) DK3285767T3 (zh)
EA (1) EA032512B1 (zh)
ES (1) ES2720035T3 (zh)
GB (1) GB201507048D0 (zh)
HK (1) HK1249865B (zh)
HU (1) HUE043871T2 (zh)
IL (1) IL254155B (zh)
MX (1) MX2017013047A (zh)
PL (1) PL3285767T3 (zh)
PT (1) PT3285767T (zh)
SG (1) SG11201707870SA (zh)
TR (1) TR201905392T4 (zh)
WO (1) WO2016170353A1 (zh)
ZA (1) ZA201705847B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201304526D0 (en) 2013-03-13 2013-04-24 Proximagen Ltd New compounds
GB201507036D0 (en) * 2015-04-24 2015-06-10 Proximagen Ltd Crystalline enzyme inhibitor compound
GB201507031D0 (en) * 2015-04-24 2015-06-10 Proximagen Ltd New pharmaceutical salt forms
CA3007768A1 (en) * 2015-12-07 2017-06-15 Benevolentai Cambridge Limited Vap-1 inhibitors for treating pain
GB201618029D0 (en) 2016-10-25 2016-12-07 Proximagen Ltd New process
GB201709136D0 (en) * 2017-06-08 2017-07-26 Proximagen Ltd New therapeutic uses of enzyme inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4055593A (en) * 1992-05-15 1993-12-13 University Of Saskatchewan Method for preventing endothelium damage in mammals and for alleviating pain associated with gout and arthritis
EP1791835A2 (en) * 2004-09-09 2007-06-06 Astellas Pharma Inc. Thiazole derivatives having vap-1 inhibitory activity
US20070066646A1 (en) * 2005-08-02 2007-03-22 Genmedica Therapeutics Sl Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof
EP3042668B1 (en) 2006-06-07 2018-09-19 The Board of Trustees of the Leland Stanford Junior University Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
TWI490214B (zh) * 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途
CN102232073B (zh) * 2008-09-16 2014-10-29 普罗克西梅根有限公司 Ssao活性抑制剂
FI20115234A0 (fi) * 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
US20160113893A1 (en) * 2013-06-12 2016-04-28 Proximagen Limited New therapeutic uses of enzyme inhibitors
ES2714125T3 (es) * 2014-04-15 2019-05-27 Pecsi Tudomanyegyetem Inhibidores de la amino oxidasa sensible a la semicarbazida para uso como analgésicos en una neuropatía traumática y una inflamación neurogénica
GB201507036D0 (en) * 2015-04-24 2015-06-10 Proximagen Ltd Crystalline enzyme inhibitor compound
GB201507031D0 (en) * 2015-04-24 2015-06-10 Proximagen Ltd New pharmaceutical salt forms

Also Published As

Publication number Publication date
EP3285767B8 (en) 2019-05-22
ZA201705847B (en) 2020-03-25
CA2979160A1 (en) 2016-10-27
HUE043871T2 (hu) 2019-09-30
EP3285767B1 (en) 2019-03-20
PL3285767T3 (pl) 2019-09-30
IL254155B (en) 2021-02-28
EP3285767A1 (en) 2018-02-28
EA201792123A1 (ru) 2018-03-30
US20180104223A1 (en) 2018-04-19
AU2016252237B2 (en) 2021-04-08
DK3285767T3 (en) 2019-04-29
SG11201707870SA (en) 2017-11-29
MX2017013047A (es) 2017-12-08
AU2016252237A1 (en) 2017-10-05
BR112017019337A2 (pt) 2018-06-05
WO2016170353A1 (en) 2016-10-27
JP2021073257A (ja) 2021-05-13
ES2720035T3 (es) 2019-07-17
EA032512B1 (ru) 2019-06-28
KR20170139047A (ko) 2017-12-18
CN107530330A (zh) 2018-01-02
GB201507048D0 (en) 2015-06-10
PT3285767T (pt) 2019-05-20
JP2018520984A (ja) 2018-08-02
IL254155A0 (en) 2017-10-31
TR201905392T4 (tr) 2019-05-21

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
IL259110A (en) Treatment of osteoarthritis (osteoarthritis)
IL283258A (en) A preparation for the treatment of hypothyroidism
FI3851537T3 (fi) Hyperbilirubinemian hoito
HK1249865B (zh) 疼痛的治療
HK1249866A1 (zh) 用他塞利昔布進行治療的方法
EP3458062A4 (en) TREATMENT OF PAIN
IL266243A (en) Use of senicapoc for the treatment of neuropathic pain
GB201604658D0 (en) Treatment for pain
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
GB201412010D0 (en) Treatment of hypertransaminasemia
HK1252359A1 (zh) 用於治療疼痛的曲唑酮和加巴噴丁的組合
GB201512139D0 (en) Methods of treatment
GB201510870D0 (en) Treatment of infarction
GB201621398D0 (en) Treatment of emt-associated disease
GB201501800D0 (en) Treatment of medical conditions
AU2016901912A0 (en) Treatment of Pain
SG10201913141UA (en) Treatment of alphavirus-induced inflammation
GB201505205D0 (en) Treatment for pain
GB201504688D0 (en) Treatment for pain
GB201504413D0 (en) Treatment of disease
GB201506944D0 (en) Therapeutic treatment
GB201514909D0 (en) Treatment of autoimmune diseases
GB201512723D0 (en) Treatment of cancer
GB201507928D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230425